Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results
Rhea-AI Summary
Accelerate Diagnostics (NASDAQ: AXDX) has announced a conference call scheduled for Thursday, August 8, 2024, at 4:30 p.m. Eastern Time to review the company's 2024 second quarter results. Investors and interested parties can access the audio webcast online at ir.axdx.com, with a replay available for 30 days. For those preferring to listen by phone, dial-in options are provided for both U.S. and international participants. A telephone replay will be accessible until August 29, 2024, using specific replay codes for U.S. and international callers.
Positive
- None.
Negative
- None.
To listen to the audio webcast online, visit ir.axdx.com. A replay of the audio webcast will be available for 30 days.
To listen by phone, dial +1.877.883.0383 and enter the Elite Entry Number: 9884567. International participants may dial +1.412.902.6506. Please dial in 10-15 minutes prior to the start of the conference.
A replay of the call will be available by telephone at +1.877.344.7529 (
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and "ACCELERATE PHENO TEST" and "ACCELERATE WAVE" and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc.
For more information about the company, its products and technology, or recent publications, visit axdx.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-scheduled-call-to-review-2024-second-quarter-results-302218055.html
SOURCE Accelerate Diagnostics, Inc.
FAQ
When is Accelerate Diagnostics (AXDX) hosting its Q2 2024 earnings call?
How can investors access Accelerate Diagnostics' (AXDX) Q2 2024 earnings call?
Until when will the replay of Accelerate Diagnostics' (AXDX) Q2 2024 earnings call be available?
What is the Elite Entry Number for Accelerate Diagnostics' (AXDX) Q2 2024 earnings call?
